Neuroscience

COVID-19 brain fog and the role of Tau proteins

A study published in PNAS Nexus identifies a molecule that may be behind cognitive symptoms, including "brain fog," experienced by those infected by the SARS-CoV-2 virus.

Alzheimer's disease & dementia

New blood test gives high accuracy screen for Alzheimer's disease

A new blood test called p-tau217 shows promise as an Alzheimer's disease biomarker, and when used in a two-step workflow very high accuracy to either identify or exclude brain amyloidosis, the most important and earliest ...

Neuroscience

'Viral relicts' in the genome could fuel neurodegeneration

Genetic remnants of viruses that are naturally present in the human genome could affect the development of neurodegenerative diseases. Researchers at DZNE have come to this conclusion based on studies of cell cultures. In ...

Alzheimer's disease & dementia

Tau PET: A window into the future of Alzheimer's patients

Alzheimer's disease, one of the most common neurodegenerative diseases, leads to progressive loss of memory and autonomy. It is characterized by the accumulation of neurotoxic proteins in the brain, namely amyloid plaques ...

page 3 from 40